New Jersey adult cannabis businesses approached Maridose's total sales for the state's second fiscal quarter, April 21 through June 30, having received licenses from the DEA and Department of Justice to mass produce marijuana to provide researchers with cannabis, cannabis extracts (including isolated chemical components) and THC. maridose is the seventh company to receive such a license, a Maine Brunswick-based cannabis pharmaceutical company. The University of Mississippi's National Center for Natural Product Development received the first DEA cultivation registration in 1968. the DEA did not grant another license for mass production of cannabis until 2021. These licenses went to: Scottsdale Research Institute in Arizona, Biopharmaceutical Research Co. in California, Groff North America in Pennsylvania, and Royal Emerald Pharmaceuticals in California. this year, the Maridose founder Richard Shain said the license is "the culmination of more than five years of collaboration with the DEA, enabling Maridose to legally sell a variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the U.S. and internationally. companies to legally sell a variety of cannabis products through the DEA." Researchers working with DEA-licensed cannabis producers must also receive approval from federal agencies to conduct cannabis research.
Information source: mjbizdaily.com/